Comparison of pharmacokinetics and urinary iron excretion of two single doses of deferiprone in ß-thalassemia/hemoglobin E patients.

Rodrat, Supot; Yamanont, Pavena; Tankanitlert, Jeeranut; Chantraraksri, Udom; Fucharoen, Suthat; Morales, Noppawan Phumala

Rodrat, Supot; Yamanont, Pavena; Tankanitlert, Jeeranut; Chantraraksri, Udom; Fucharoen, Suthat; Morales, Noppawan Phumala.

Affiliation

Rodrat S; Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand.

Pharmacology ; 90(1-2): 88-94, 2012.

Article in En | MEDLINE | ID: mdl-22759897

Subject(s)

Iron Chelating Agents/pharmacokinetics; Iron/urine; Pyridones/pharmacokinetics; beta-Thalassemia/urine; Adolescent; Adult; Area Under Curve; Deferiprone; Female; Glucuronides/urine; Hemoglobin E; Humans; Male; Middle Aged; Pyridones/urine; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pyridones / Iron Chelating Agents / Beta-Thalassemia / Iron Type of study: Prognostic_studies Language: En Journal: Pharmacology Year: 2012 Type: Article Affiliation country: Thailand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google